The Eli Lilly & Co. logo in the Digital Health Innovation Hub facility of the company in Singapore, on Thursday, November 14, 2024.
Erz huiying | Bloomberg | Getty pictures
Eli Lilly On Thursday, sales and profits reported in the first quarter, which were estimated as a demand for weight loss and diabetes medication, but reduced their profit guidelines of the entire year due to charges in connection with a recently carried out cancer treatment contract.
The pharmaceutical now assumes that its adjusted result for the 2025 financial year is between $ 20.78 and $ 22.28 per share from USD $ 24 per share.
Eli Lilly kept his sales advice of 58 billion US dollars up to $ 61 billion.
The following reported Eli Lilly in the first quarter compared to what Wall Street expected, based on a survey of LSEG analysts:
This story develops. Please check for updates.
The Eclipse season is a season in which the larger layers occur internally and externally.…
Last update: 04/30/2025 | 23:36 Related topics: Majd Kimri Jaroshi, a inhabitant of Ramla, was…
Before the day of independence, the Israelis took on butchers to stock up on roast…
Environmental health perspectives, which are generally regarded as the first -class journal for environmental health,…
Larry Ellison, co-founder and executive Chairman from Oracle Corp., speaks on Monday, October 22, 2018,…
When a person develops solid tumors in the stomach, in the esophagus or in the…
This website uses cookies.